Skip navigation
Speakers

Strategies to Scale the Business and Best Practices for Accounting and Reporting

September 24-25, 2019
  • Boston, MA

Yasir B. Al-Wakeel
Chief Financial Officer
Neon Therapeutics

Cindy Anderson
Chief Accounting Officer
Alnylam

Nancy Aubrey
Partner, Risk Advisory Services,
Biotech/Life Science Industry
RSM US LLP

Chip Baird
Chief Financial Officer
bluebird bio (Invited)

Lidia Borshcheva
Director, Valuation Services
CFGI

Richard Butterworth
Senior Director Alliance Management,
Service Provider Management, Global Clinical Operations
Merck

Rick Capasso
Executive Director, Financial Accounting Advisory,
Services, Life Sciences
Ernst & Young LLP

Chris Cobourn
Managing Director
KPMG LLP

Gina Consylman
Chief Financial Officer
Ironwood Pharmaceuticals

Michael Corrente
Managing Director & Leader, New England Life Sciences Practice
CBIZ & MHM

Jack Crowley
CFO
PGDx, Inc.

Gisele Dion
Chief Accounting Officer
Takeda

Barbara Duncan
Biotech Board Member (Invited)

Ed Fitzgerald
former Chief Financial Officer, ARIAD Pharmaceuticals;
Biotech Board Member (Invited)

Jon Freve
Chief Financial Officer
Spring Bank Pharmaceuticals

Daimon Geopfert
National Leader, Security & Privacy Risk Consulting
RSM US LLP

Mary Anne Henry
Director, New England Tax Group
CBIZ & MHM

Howard Horn
Chief Financial Officer
VIR Biotechnology (Invited)

Troy Ignelzi
Chief Financial Officer
Karuna Therapeutics

Jennifer Kimmel
National Assurance Director
BDO

Philip Koesters
Senior Director, Accounting
Sunovion Pharmaceuticals

Shane Kovacs
Chief Business and Financial Officer
BlueRock Therapeutics

John Lanza
Partner, National Life Sciences Industry Leader
RSM US LLP

Frank Leu
Chief Executive Officer
Novapeutics

Mark Levin
Co-Founder
Third Rock Ventures (Invited)

David Lewin
Managing Director & Leader,
New England Accounting Advisory Practice
CBIZ & MHM

David Lowrance
Chief Financial Officer
Savara Pharmaceuticals

Michael Mason
Chief Financial Officer
Karyopharm

Tom McGauley
Director, New England Accounting Advisory Practice
CBIZ & MHM

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Melanie Morel-Ferris
Controller
Akcea Therapeutics

James Neal
Managing Partner
AdaptaLogix

William Roberts
Partner
Ernst & Young LLP

Jennifer Sharpe
Executive Advisor, Revenue Analytics Collaborative
IntegriChain

Lynn Sullivan
Chief Financial Officer
Compass Therapeutics (Invited)

Ryan Udell
Partner, Chair, Corporate and Securities Group
White & Williams LLP

Tracey Walker
National Senior Director, Government Affairs;
Culture, Diversity and Inclusion, RSM US LLP

Michael Webster
Director, Technology Consulting
RSM US, LLP

Robert Wells
Managing Director
CFGI

Matt Wolf
Director, Life Sciences Senior Analyst
RSM US LLP

Yasir B. Al-Wakeel
Chief Financial Officer
Neon Therapeutics

Cindy Anderson
Chief Accounting Officer
Alnylam

Nancy Aubrey
Partner, Risk Advisory Services,
Biotech/Life Science Industry
RSM US LLP

Chip Baird
Chief Financial Officer
bluebird bio (Invited)

Lidia Borshcheva
Director, Valuation Services
CFGI

Richard Butterworth
Senior Director Alliance Management,
Service Provider Management, Global Clinical Operations
Merck

Rick Capasso
Executive Director, Financial Accounting Advisory,
Services, Life Sciences
Ernst & Young LLP

Chris Cobourn
Managing Director
KPMG LLP

Gina Consylman
Chief Financial Officer
Ironwood Pharmaceuticals

Michael Corrente
Managing Director & Leader, New England Life Sciences Practice
CBIZ & MHM

Jack Crowley
CFO
PGDx, Inc.

Gisele Dion
Chief Accounting Officer
Takeda

Barbara Duncan
Biotech Board Member (Invited)

Ed Fitzgerald
former Chief Financial Officer, ARIAD Pharmaceuticals;
Biotech Board Member (Invited)

Jon Freve
Chief Financial Officer
Spring Bank Pharmaceuticals

Daimon Geopfert
National Leader, Security & Privacy Risk Consulting
RSM US LLP

Mary Anne Henry
Director, New England Tax Group
CBIZ & MHM

Howard Horn
Chief Financial Officer
VIR Biotechnology (Invited)

Troy Ignelzi
Chief Financial Officer
Karuna Therapeutics

Jennifer Kimmel
National Assurance Director
BDO

Philip Koesters
Senior Director, Accounting
Sunovion Pharmaceuticals

Shane Kovacs
Chief Business and Financial Officer
BlueRock Therapeutics

John Lanza
Partner, National Life Sciences Industry Leader
RSM US LLP

Frank Leu
Chief Executive Officer
Novapeutics

Mark Levin
Co-Founder
Third Rock Ventures (Invited)

David Lewin
Managing Director & Leader,
New England Accounting Advisory Practice
CBIZ & MHM

David Lowrance
Chief Financial Officer
Savara Pharmaceuticals

Michael Mason
Chief Financial Officer
Karyopharm

Tom McGauley
Director, New England Accounting Advisory Practice
CBIZ & MHM

Ted Myles
Executive Vice President and Chief Financial Officer
AMAG Pharmaceuticals

Melanie Morel-Ferris
Controller
Akcea Therapeutics

James Neal
Managing Partner
AdaptaLogix

William Roberts
Partner
Ernst & Young LLP

Jennifer Sharpe
Executive Advisor, Revenue Analytics Collaborative
IntegriChain

Lynn Sullivan
Chief Financial Officer
Compass Therapeutics (Invited)

Ryan Udell
Partner, Chair, Corporate and Securities Group
White & Williams LLP

Tracey Walker
National Senior Director, Government Affairs;
Culture, Diversity and Inclusion, RSM US LLP

Michael Webster
Director, Technology Consulting
RSM US, LLP

Robert Wells
Managing Director
CFGI

Matt Wolf
Director, Life Sciences Senior Analyst
RSM US LLP